Population pharmacokinetics and optimized prophylaxis dosing of cefazolin during transcatheter aortic valve implantation
This study found a 2 g dose of cefazolin achieved target exposure for MSSA but was subthreshold for other pathogens.
Authors
- Christopher Robson (ORCID: https://orcid.org/0000-0002-4393-3308)
- Rhonda L. Stuart (ORCID: https://orcid.org/0000-0002-3487-7244)
- Jason A. Roberts (ORCID: https://orcid.org/0000-0001-6218-435X)
- Hoyoun Won (ORCID: https://orcid.org/0000-0001-7880-3477)
- Benjamin A. Rogers (ORCID: https://orcid.org/0000-0001-6515-2118)
- Steven C. Wallis (ORCID: https://orcid.org/0000-0002-2392-9854)
- Rob Gooley
- Stephen James Nicholls (ORCID: https://orcid.org/0000-0002-9668-4368)
- Omar Al‐Mukhtar (ORCID: https://orcid.org/0000-0002-4208-4586)
- Xin Liu (ORCID: https://orcid.org/0000-0002-6210-8100)
Institutions
- The University of Queensland (AU)
- Université de Montpellier (FR)
- Royal Brisbane and Women's Hospital (AU)
- Epworth Hospital (AU)
- Eastern Health (AU)
- Infectious Diseases Institute (UG)
- Western Health (AU)
- Monash Health (AU)
- Monash University (AU)
- Université de Nîmes (FR)
Publication Details
- Journal
- Journal of Antimicrobial Chemotherapy
- Published
- 2025-03-20
- DOI
- https://doi.org/10.1093/jac/dkaf108
- Citations
- 1
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35